Holen Sie sich die Stockscreener-App
13.50
0.37%
0.05
Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
27.61%
35.36
|
27.71 | 26.27 | 15.73 | 14.94 |
| Operating Income/Loss |
27.61%
-35.36
|
-27.71 | -26.27 | -15.73 | -14.94 |
| Nonoperating Income/Loss |
16.01%
3.854
|
3.322 | 3.513 | 3.594 | 2.33 |
| Income/Loss From Continuing Operations Before Tax |
29.19%
-31.51
|
-24.39 | -22.76 | -12.14 | -12.61 |
| Income/Loss From Continuing Operations After Tax |
29.19%
-31.51
|
-24.39 | -22.76 | -12.14 | -12.61 |
|
Net Income/Loss
|
29.19%
-31.51
|
-24.39 | -22.76 | -12.14 | -12.61 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,312%
44.90
|
1.316 | 39.93 | 39.75 | 24.76 |
| Diluted Average Shares |
3,312%
44.90
|
1.316 | 39.93 | 39.75 | 24.76 |
| Basic Earnings Per Share |
11.11%
-0.70
|
-0.63 | -0.57 | -0.31 | -0.51 |
| Diluted Earnings Per Share |
11.11%
-0.70
|
-0.63 | -0.57 | -0.31 | -0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.11%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):